SCHEMBL22981883

SCHEMBL22981883

COCc1nn(Cc2ccc3c(c2)CCN(C2CC2)C3)cc1C(=O)NCc1c(-n2ccc(C#N)n2)ccc(OC)c1F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 9/20 1.00
▸ F11 P03951 11/20 0.95

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29405556 1.00 KLKB1 (1.00) KLKB1F11
SCHEMBL29407573 0.98 F11 (1.00) KLKB1F11
SCHEMBL29697605 0.92 F11 (1.00) KLKB1F11
SCHEMBL22981963 0.92 F11 (1.00) KLKB1F11
SCHEMBL29407418 0.90 F11 (0.95) KLKB1F11
SCHEMBL29407429 0.90 F11 (0.95) KLKB1F11
SCHEMBL22982169 0.90 F11 (0.95) KLKB1F11
SCHEMBL22982463 0.90 F11 (1.00) KLKB1F11
SCHEMBL29697644 0.90 F11 (1.00) KLKB1F11
SCHEMBL29697529 0.88 F11 (1.00) KLKB1F11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010333-A1 PLASMA KALLIKREIN INHIBITORS Kalvista Pharmaceuticals Limited (GB) 2022-06-15 — — EP disclosed
WO-2021028645-A1 PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-18 — — WO disclosed
WO-2021028649-A1 PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-18 — — WO disclosed
Send feedback